RVLPQ (RVL Pharmaceuticals) Effective Interest Rate on Debt %: 21.79% (As of Jun. 2023)


RVLPQ RVL Pharmaceuticals PLC RVLPQ
12 GF Score
Price $0.00
View Full Analysis

What is RVL Pharmaceuticals Effective Interest Rate on Debt %?

RVL Pharmaceuticals RVLPQ -90.00% 12 Effective Interest Rate on Debt % is 21.79% as of Jun. 2023. GuruFocus rates RVLPQ with a GF Score™ of 12/100.

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. RVL Pharmaceuticals's annualized positive value of Interest Expense for the quarter that ended in Jun. 2023 was $12.63 Mil. RVL Pharmaceuticals's average total debt for the quarter that ended in Jun. 2023 was $57.95 Mil. Therefore, RVL Pharmaceuticals's annualized Effective Interest Rate on Debt % for the quarter that ended in Jun. 2023 was 21.79%.

RVL Pharmaceuticals  (OTCPK:RVLPQ) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

RVL Pharmaceuticals Effective Interest Rate on Debt % Related Terms

RVL Pharmaceuticals Effective Interest Rate on Debt % Historical Data

* Premium members only.

The historical data trend for RVL Pharmaceuticals's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RVL Pharmaceuticals Effective Interest Rate on Debt % Chart

RVL Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Effective Interest Rate on Debt %
Get a 7-Day Free Trial 7.05 6.72 1.65 2.98 5.92

RVL Pharmaceuticals Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.49 -31.10 33.44 51.20 21.79

RVLPQ vs SNPX, THAR, SLRX: Effective Interest Rate on Debt % Comparison

For the Biotechnology subindustry, RVL Pharmaceuticals's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RVL Pharmaceuticals Effective Interest Rate on Debt % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, RVL Pharmaceuticals's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where RVL Pharmaceuticals's Effective Interest Rate on Debt % falls into.


RVLPQ
12GF Score
RVL Pharmaceuticals PLC RVLPQ
Effective Interest Rate on Debt % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

RVL Pharmaceuticals Effective Interest Rate on Debt % Calculation

RVL Pharmaceuticals's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2022 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Dec. 2021 )+Total Debt  (A: Dec. 2022 ))/ count )
=-1  *  -3.11/( (47.645+57.489)/ 2 )
=-1  *  -3.11/52.567
=5.92 %

where

Total Debt  (A: Dec. 2021 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=44.392 + 3.253
=47.645

Total Debt  (A: Dec. 2022 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=55.612 + 1.877
=57.489

RVL Pharmaceuticals's annualized Effective Interest Rate on Debt % for the quarter that ended in Jun. 2023 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Mar. 2023 )+Total Debt  (Q: Jun. 2023 ))/ count )
=-1  *  -12.628/( (57.75+58.147)/ 2 )
=-1  *  -12.628/57.9485
=21.79 %

where

Total Debt  (Q: Mar. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=53.283 + 4.467
=57.75

Total Debt  (Q: Jun. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.192 + 57.955
=58.147

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Jun. 2023) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

What does a Effective Interest Rate on Debt % of 21.79% mean?
RVL Pharmaceuticals (RVLPQ) has a Effective Interest Rate on Debt % of 21.79% as of Jun. 2023. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on RVL Pharmaceuticals and its competitors.
Is RVL Pharmaceuticals' Effective Interest Rate on Debt % too high?
RVL Pharmaceuticals' current Effective Interest Rate on Debt % is 21.79%. Overall, RVL Pharmaceuticals has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does RVL Pharmaceuticals' Effective Interest Rate on Debt % compare to SNPX and THAR?
RVL Pharmaceuticals' Effective Interest Rate on Debt % of 21.79% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Effective Interest Rate on Debt % for a Biotechnology company?
A good Effective Interest Rate on Debt % depends on the Biotechnology industry context. However, Effective Interest Rate on Debt % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Effective Interest Rate on Debt % mean?
A high Effective Interest Rate on Debt % can signal that a stock is expensive relative to its fundamentals. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on RVL Pharmaceuticals and its competitors. RVL Pharmaceuticals's current Effective Interest Rate on Debt % is 21.79%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RVL Pharmaceuticals stock overvalued right now?
RVL Pharmaceuticals (RVLPQ) has a current Effective Interest Rate on Debt % of 21.79%. The current Effective Interest Rate on Debt % is 21.79%. RVL Pharmaceuticals' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Effective Interest Rate on Debt % calculated?
Effective Interest Rate on Debt % is calculated from a company's financial statements. For RVL Pharmaceuticals (RVLPQ), the current Effective Interest Rate on Debt % is 21.79% as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RVL Pharmaceuticals Business Description

Address 400 Crossing Boulevard, Bridgewater, NJ, USA, 08807
RVL Pharmaceuticals PLC is a pharmaceutical company focused on the commercialization and development of products that target markets with underserved patient populations in the ocular medicine and medical aesthetics therapeutic areas. Its revenues consist of product sales, royalty revenues and licensing revenue.
12GF Score

Get the complete analysis for RVLPQ

Effective Interest Rate on Debt % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price